Prevalence of metabolic syndrome in patients with psoriasis: a hospital‐based case–control study
暂无分享,去创建一个
S. Piaserico | A. Giannetti | P. Gisondi | G. Girolomoni | G. Tessari | A. Peserico | S. Piaserico | A. Giannetti | P. Gisondi | G. Tessari | A. Conti | S. Schianchi | A. Peserico | G. Girolomoni | A. Conti | S. Schianchi | S. Schianchi | Simona Schianchi
[1] P. Zimmet,et al. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.
[2] John A Spertus,et al. Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement Executive Summary , 2005, Critical pathways in cardiology.
[3] Jukka T Salonen,et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. , 2002, JAMA.
[4] P. Gisondi,et al. Plasma homocysteine and folate levels in patients with chronic plaque psoriasis , 2006, The British journal of dermatology.
[5] Ralph B D'Agostino,et al. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. , 2006, The Journal of clinical endocrinology and metabolism.
[6] Jing Chen,et al. Prevalence of the metabolic syndrome and overweight among adults in China , 2005, The Lancet.
[7] J. Shaw,et al. The metabolic syndrome: prevalence in worldwide populations. , 2004, Endocrinology and metabolism clinics of North America.
[8] A. Drosos,et al. Effects of infliximab treatment on insulin resistance in patients with rheumatoid arthritis and ankylosing spondylitis , 2004, Annals of the rheumatic diseases.
[9] B. Balkau,et al. Comment on the provisional report from the WHO consultation , 1999, Diabetic medicine : a journal of the British Diabetic Association.
[10] L. Naldi,et al. Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study. , 2005, The Journal of investigative dermatology.
[11] N. Bornstein,et al. Prevalence and risk factors of atherosclerosis in patients with psoriatic arthritis. , 2007, Seminars in arthritis and rheumatism.
[12] H. Minuk,et al. Metabolic syndrome. , 2005, Journal of insurance medicine.
[13] N. Rose. Autoimmune diseases. , 1981, Scientific American.
[14] L Naldi,et al. Traditional therapies in the management of moderate to severe chronic plaque psoriasis: an assessment of the benefits and risks , 2005, The British journal of dermatology.
[15] Daniel B. Shin,et al. Risk of myocardial infarction in patients with psoriasis. , 2006, JAMA.
[16] E. Sijbrands,et al. Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients. , 2007, Atherosclerosis.
[17] M. Weichenthal,et al. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis , 2006, Archives of Dermatological Research.
[18] R. Krauss,et al. Diagnosis and management of the metabolic syndrome , 2005 .
[19] Cristina Bianchi,et al. Prevalence of the metabolic syndrome among Italian adults according to ATP III definition. , 2005, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[20] Tebeb Gebretsadik,et al. Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors. , 2005, Arthritis and rheumatism.
[21] E. Martínez-Abundis,et al. Lipid profile, insulin secretion, and insulin sensitivity in psoriasis. , 2003, Journal of the American Academy of Dermatology.
[22] Richard W Morris,et al. Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. , 2005, Archives of internal medicine.
[23] D. Moller,et al. Metabolic syndrome: a clinical and molecular perspective. , 2005, Annual review of medicine.
[24] S. Weiss. Obesity: insight into the origins of asthma , 2005, Nature Immunology.
[25] G. Krueger,et al. Psoriasis--recent advances in understanding its pathogenesis and treatment. , 2005, Journal of the American Academy of Dermatology.
[26] A. Kimball,et al. The Psychosocial Burden of Psoriasis , 2005, American journal of clinical dermatology.
[27] Fernando Costa,et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. , 2005, Circulation.
[28] C. Ritchlin,et al. Metabolic disorders in patients with psoriasis and psoriatic arthritis , 2006, Current rheumatology reports.
[29] R. D'Agostino,et al. Metabolic Syndrome as a Precursor of Cardiovascular Disease and Type 2 Diabetes Mellitus , 2005, Circulation.
[30] T Fredriksson,et al. Severe psoriasis--oral therapy with a new retinoid. , 1978, Dermatologica.
[31] R. Langley,et al. Evaluating psoriasis with Psoriasis Area and Severity Index, Psoriasis Global Assessment, and Lattice System Physician's Global Assessment. , 2004, Journal of the American Academy of Dermatology.
[32] F. Granath,et al. Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients , 2003, European Journal of Epidemiology.
[33] A. Hamsten,et al. Psoriasis is associated with lipid abnormalities at the onset of skin disease. , 2006, Journal of the American Academy of Dermatology.
[34] Y. Shoenfeld,et al. Mechanisms of Disease: atherosclerosis in autoimmune diseases , 2006, Nature Clinical Practice Rheumatology.
[35] Giampiero Girolomoni,et al. Prevalence of psoriatic arthritis and joint complaints in a large population of Italian patients hospitalised for psoriasis. , 2005, European journal of dermatology : EJD.
[36] Dafna Gladman,et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. , 2006, Arthritis and rheumatism.
[37] R. Stern,et al. Epidemiology of psoriatic arthritis in the population of the United States. , 2005, Journal of the American Academy of Dermatology.
[38] R. Hardy,et al. The metabolic syndrome: A high-risk state for cancer? , 2006, The American journal of pathology.
[39] Fernando Costa,et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. , 2006, Current opinion in cardiology.
[40] Daniel B. Shin,et al. Prevalence of cardiovascular risk factors in patients with psoriasis. , 2006, Journal of the American Academy of Dermatology.
[41] Herbert Tilg,et al. Adipocytokines: mediators linking adipose tissue, inflammation and immunity , 2006, Nature Reviews Immunology.
[42] Michael Hinckley,et al. Impact of obesity and smoking on psoriasis presentation and management. , 2005, Archives of dermatology.
[43] A. Wahba-Yahav. Disease concomitance in psoriasis. , 1996, Journal of the American Academy of Dermatology.